NASDAQ:LIVN LivaNova (LIVN) Stock Price, News & Analysis $94.54 +2.62 (+2.85%) Closing price 11/18/2026 04:00 PM EasternExtended Trading$95.23 +0.69 (+0.73%) As of 11/18/2026 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About LivaNova Stock (NASDAQ:LIVN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get LivaNova alerts:Sign Up Key Stats Today's Range$90.20▼$95.4050-Day Range$74.70▼$94.5452-Week Range$53.37▼$99.38Volume1.32 million shsAverage Volume782,874 shsMarket Capitalization$5.21 billionP/E Ratio25.18Dividend YieldN/APrice Target$101.22Consensus RatingModerate Buy Company Overview LivaNova plc is a global medical technology company that develops and manufactures products for cardiovascular care and neuromodulation. The company was formed in 2015 through the combination of Cyberonics and Sorin Group. In neuromodulation, LivaNova’s VNS Therapy system delivers vagus nerve stimulation and is used as an adjunctive treatment for certain people with drug-resistant epilepsy and treatment-resistant depression. Its cardiovascular products support cardiac surgery and include heart-lung machines, oxygenators and related perfusion equipment. LivaNova serves healthcare providers and patients in markets around the world, with products used in hospitals and other clinical settings.AI Generated. May Contain Errors. Read More LivaNova Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks42nd Percentile Overall ScoreLIVN MarketRank™: 2.110004094445 of 5 starsLivaNova scored higher than 42% of companies evaluated by MarketBeat, and ranked 1223rd out of 1,704 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.9 / 5Analyst RatingModerate Buy Consensus RatingLivaNova has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on no strong buy ratings, 9 buy ratings, 3 hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for LivaNova is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageLivaNova has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about LivaNova's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth12.23% Earnings GrowthEarnings for LivaNova are expected to grow by 12.23% in the coming year, from $3.76 to $4.22 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of LivaNova is 25.18, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.55.Price to Earnings Ratio vs. SectorThe P/E ratio of LivaNova is 25.18, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.52.Price to Book Value per Share RatioLivaNova has a P/B Ratio of 3.80. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted11.59% of the float of LivaNova has been sold short.Short Interest Ratio / Days to CoverLivaNova has a short interest ratio ("days to cover") of 12.42, which indicates bearish sentiment.Change versus previous monthShort interest in LivaNova has recently increased by 2.63%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldLivaNova does not currently pay a dividend.Dividend GrowthLivaNova does not have a long track record of dividend growth. News and Social Media2.6 / 5News Sentiment0.15 News SentimentLivaNova has a news sentiment score of 0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 5 news articles for LivaNova this week, compared to 3 articles on an average week.Search Interest1 people have searched for LIVN on MarketBeat in the last 30 days. Company Ownership1.4 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, LivaNova insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $819,114.00 in company stock.Percentage Held by Insiders0.35% of the stock of LivaNova is held by insiders.Percentage Held by Institutions97.64% of the stock of LivaNova is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about LivaNova's insider trading history. Receive LIVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LivaNova and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LIVN Stock News HeadlinesMedical costs are crushing insurers—and lifting LivaNova stockNovember 18 at 11:26 AM | finance.yahoo.comLivaNova (NASDAQ:LIVN) Stock: Insider Alex Shvartsburg Sells 2,500 SharesNovember 15, 2026 | insidertrades.comYou missed yesterday's deadline…In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars. | Behind the Markets (Ad)LivaNova: Paying Off The Last Legacy Bill Just As The Sleep Apnea Market Opens UpNovember 12, 2026 | seekingalpha.comLivaNova (NASDAQ:LIVN) Stock Price Expected to Rise, Barclays Analyst SaysNovember 11, 2026 | americanbankingnews.comLivaNova Earnings Call Signals Strong Growth AheadNovember 9, 2026 | theglobeandmail.comLivaNova PLC (LIVN) Presents at 2026 UBS Global Healthcare Conference TranscriptNovember 9, 2026 | seekingalpha.comLivaNova PLC 2026 Q3 - Results - Earnings Call PresentationNovember 6, 2026 | seekingalpha.comSee More Headlines LIVN Stock Analysis - Frequently Asked Questions How have LIVN shares performed this year? LivaNova's stock was trading at $61.53 at the beginning of 2026. Since then, LIVN shares have increased by 53.6% and is now trading at $94.54. How were LivaNova's earnings last quarter? LivaNova PLC (NASDAQ:LIVN) posted its quarterly earnings data on Wednesday, November, 4th. The company reported $1.23 EPS for the quarter, topping analysts' consensus estimates of $1.06 by $0.17. The firm's revenue was up 9.9% compared to the same quarter last year. Read the conference call transcript. Who are LivaNova's major shareholders? LivaNova's top institutional shareholders include State Street Corp (3.93%), Congress Asset Management Co. (2.73%), Bellevue Group AG (0.30%) and CSM Advisors LLC (0.25%). Insiders that own company stock include Alex Shvartsburg, Daniel Jeffrey Moore, Brooke Story and Francesco Bianchi. View institutional ownership trends. How do I buy shares of LivaNova? Shares of LIVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of LivaNova own? Based on aggregate information from My MarketBeat watchlists, some other companies that LivaNova investors own include GE Aerospace (GE), Kinder Morgan (KMI), Wells Fargo & Company (WFC), Exact Sciences (EXAS), Diamondback Energy (FANG), Genocea Biosciences (GNCA) and Incyte (INCY). Company Calendar Last Earnings11/04/2026Today11/18/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 LIVN's financial health is in the Green zone, according to TradeSmith. LIVN has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:LIVN CIK1639691 Webwww.livanova.com Phone442033250660Fax281-218-9332Employees3,300Year Founded2015Price Target and Rating Average Price Target for LivaNova$101.22 High Price Target$120.00 Low Price Target$66.00 Potential Upside/Downside+7.1%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage12 Analysts Profitability EPS (Trailing Twelve Months)$3.00 Trailing P/E Ratio25.18 Forward P/E Ratio22.40 P/E GrowthN/ANet Income-$242.47 million Net Margins13.01% Pretax Margin7.99% Return on Equity16.10% Return on Assets7.85% Debt Debt-to-Equity Ratio0.22 Current Ratio1.46 Quick Ratio1.22 Sales & Book Value Annual Sales$1.39 billion Price / Sales3.75 Cash Flow$4.97 per share Price / Cash Flow19.01 Book Value$24.91 per share Price / Book3.80Miscellaneous Outstanding Shares55,090,000Free Float54,894,000Market Cap$5.21 billion OptionableOptionable Beta0.91 Social Links 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NASDAQ:LIVN) was last updated on 11/18/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | Sponsored6 Men Secretly Changed America’s Money. Now It’s Happening AgainIn 1910, six powerful men secretly met to lay the groundwork for the Federal Reserve, reshaping America's fina...Banyan Hill Publishing | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored432 miles southeast of Washington, DC…Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip mak...Wall Street Watchdogs | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LivaNova PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share LivaNova With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.